Industry: Service & Software
Published Date: 2026-03-05
Pages: 161 Pages
Report ld: 5552749
Request Sample
Customized Report
Artificial Intelligence Diagnostics Market Size(US$)

CAGR 2026-2032
20.9%
Market Size,2032
USD 27,456
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Artificial Intelligence Diagnostics was estimated to be worth US$ 7259 million in 2025 and is projected to reach US$ 27456 million, growing at a CAGR of 20.9% from 2026 to 2032.
Artificial Intelligence Diagnostics refers to regulated software systems that apply machine learning, deep learning, and advanced analytics to clinical data in order to support or deliver diagnostic decisions. Unlike general clinical analytics, AI diagnostics are designed to influence medical judgment by identifying disease, assessing severity, or recommending diagnostic conclusions based on inputs such as medical imaging, physiological signals (e.g., ECG, EEG), ophthalmic images, laboratory patterns, and multi-modal clinical data. Most solutions are commercialized as Software as a Medical Device (SaMD) and operate under strict regulatory frameworks such as FDA clearance or CE marking. AI diagnostics do not replace physicians but function as decision-support or physician-in-the-loop systems, improving diagnostic accuracy, speed, and consistency across healthcare settings.
Artificial Intelligence Diagnostics refers to regulated software systems that apply machine learning, deep learning, and advanced analytics to
The market can be classified by diagnostic data type (imaging-based, physiological signal-based, ophthalmic, multi-modal), by diagnostic role (screening, diagnostic assistance, automated diagnosis, severity assessment, therapy guidance), by clinical specialty (radiology, cardiology, neurology, ophthalmology, oncology, primary care), by deployment model (standalone SaMD, cloud SaaS, device-embedded, edge or wearable-based), and by regulatory/commercial type (FDA/CE-cleared diagnostic AI, clinical decision support, screening-only solutions).
Upstream players include medical device OEMs, sensor and imaging hardware suppliers, cloud and GPU infrastructure providers, and healthcare institutions contributing annotated clinical datasets. Midstream consists of AI diagnostics developers responsible for algorithm design, clinical validation, regulatory approval, and system integration with hospital IT. Downstream customers are hospitals, diagnostic centers, physician groups, and population-health programs, purchasing AI diagnostics through enterprise software contracts, bundled device sales, or subscription platforms.
Key costs arise from data acquisition and labeling, clinical trials, regulatory compliance, and continuous model maintenance. Due to software-driven economics, gross margins typically range from 65% to 80%. Transactions are dominated by subscription SaaS, per-use pricing, and multi-year enterprise licenses, increasingly bundled with devices or workflow platforms. Market trends include rapid expansion beyond radiology into cardiology and primary care, accelerated regulatory approvals, consolidation through M&A, and rising adoption driven by clinician shortages and value-based care models.
This report provides a comprehensive view of the global market for Artificial Intelligence Diagnostics, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Artificial Intelligence Diagnostics market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Diagnostics.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Artificial Intelligence Diagnostics companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Artificial Intelligence Diagnostics revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Artificial Intelligence Diagnostics revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Artificial Intelligence Diagnostics Product Introduction
1.2 Global Artificial Intelligence Diagnostics Market Size Forecast (2021–2032)
1.3 Artificial Intelligence Diagnostics Market Trends & Drivers
1.3.1 Artificial Intelligence Diagnostics Industry Trends
1.3.2 Artificial Intelligence Diagnostics Market Drivers & Opportunities
1.3.3 Artificial Intelligence Diagnostics Market Challenges
1.3.4 Artificial Intelligence Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Intelligence Diagnostics Players Revenue Ranking (2025)
2.2 Global Artificial Intelligence Diagnostics Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Artificial Intelligence Diagnostics Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Artificial Intelligence Diagnostics
2.6 Artificial Intelligence Diagnostics Market Competitive Analysis
2.6.1 Artificial Intelligence Diagnostics Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Artificial Intelligence Diagnostics Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Artificial Intelligence Diagnostics revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Artificial Intelligence Diagnostics Market Classification
3.1 Introduction by Type
3.1.1 Services
3.1.2 Software
3.1.3 Hardware
3.1.4 Global Artificial Intelligence Diagnostics Sales Value by Type
3.1.4.1 Global Artificial Intelligence Diagnostics Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Artificial Intelligence Diagnostics Sales Value, by Type (2021–2032)
3.1.4.3 Global Artificial Intelligence Diagnostics Sales Value, by Type (%), 2021–2032
3.2 Introduction by Diagnostic Data Type
3.2.1 Medical Imaging–based
3.2.2 Physiological Signals–based
3.2.3 Ophthalmic Imaging–based
3.2.4 Others
3.2.5 Global Artificial Intelligence Diagnostics Sales Value by Diagnostic Data Type
3.2.5.1 Global Artificial Intelligence Diagnostics Sales Value by Diagnostic Data Type (2021 vs 2025 vs 2032)
3.2.5.2 Global Artificial Intelligence Diagnostics Sales Value, by Diagnostic Data Type (2021–2032)
3.2.5.3 Global Artificial Intelligence Diagnostics Sales Value, by Diagnostic Data Type (%), 2021–2032
3.3 Introduction by Deployment & Delivery
3.3.1 On-prem
3.3.2 Cloud SaaS
3.3.3 Edge / Embedded
3.3.4 Hybrid
3.3.5 Others
3.3.6 Global Artificial Intelligence Diagnostics Sales Value by Deployment & Delivery
3.3.6.1 Global Artificial Intelligence Diagnostics Sales Value by Deployment & Delivery (2021 vs 2025 vs 2032)
3.3.6.2 Global Artificial Intelligence Diagnostics Sales Value, by Deployment & Delivery (2021–2032)
3.3.6.3 Global Artificial Intelligence Diagnostics Sales Value, by Deployment & Delivery (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Radiology
4.1.2 Oncology
4.1.3 Neurology
4.1.4 Cardiology
4.1.5 Chest & Lungs
4.1.6 Others
4.2 Global Artificial Intelligence Diagnostics Sales Value by Application
4.2.1 Global Artificial Intelligence Diagnostics Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Artificial Intelligence Diagnostics Sales Value by Application (2021–2032)
4.2.3 Global Artificial Intelligence Diagnostics Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Artificial Intelligence Diagnostics Sales Value by Region
5.1.1 Global Artificial Intelligence Diagnostics Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Artificial Intelligence Diagnostics Sales Value by Region (2021–2026)
5.1.3 Global Artificial Intelligence Diagnostics Sales Value by Region (2027–2032)
5.1.4 Global Artificial Intelligence Diagnostics Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Artificial Intelligence Diagnostics Sales Value, 2021–2032
5.2.2 North America Artificial Intelligence Diagnostics Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Artificial Intelligence Diagnostics Sales Value, 2021–2032
5.3.2 Europe Artificial Intelligence Diagnostics Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Intelligence Diagnostics Sales Value, 2021–2032
5.4.2 Asia Pacific Artificial Intelligence Diagnostics Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Artificial Intelligence Diagnostics Sales Value, 2021–2032
5.5.2 South America Artificial Intelligence Diagnostics Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Artificial Intelligence Diagnostics Sales Value, 2021–2032
5.6.2 Middle East & Africa Artificial Intelligence Diagnostics Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Intelligence Diagnostics Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Artificial Intelligence Diagnostics Sales Value, 2021–2032
6.3 United States
6.3.1 United States Artificial Intelligence Diagnostics Sales Value, 2021–2032
6.3.2 United States Artificial Intelligence Diagnostics Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Artificial Intelligence Diagnostics Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Artificial Intelligence Diagnostics Sales Value, 2021–2032
6.4.2 Europe Artificial Intelligence Diagnostics Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Artificial Intelligence Diagnostics Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Artificial Intelligence Diagnostics Sales Value, 2021–2032
6.5.2 China Artificial Intelligence Diagnostics Sales Value by Type (%), 2025 vs 2032
6.5.3 China Artificial Intelligence Diagnostics Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Artificial Intelligence Diagnostics Sales Value, 2021–2032
6.6.2 Japan Artificial Intelligence Diagnostics Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Artificial Intelligence Diagnostics Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Artificial Intelligence Diagnostics Sales Value, 2021–2032
6.7.2 South Korea Artificial Intelligence Diagnostics Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Artificial Intelligence Diagnostics Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Intelligence Diagnostics Sales Value, 2021–2032
6.8.2 Southeast Asia Artificial Intelligence Diagnostics Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Artificial Intelligence Diagnostics Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Artificial Intelligence Diagnostics Sales Value, 2021–2032
6.9.2 India Artificial Intelligence Diagnostics Sales Value by Type (%), 2025 vs 2032
6.9.3 India Artificial Intelligence Diagnostics Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Butterfly Network
7.1.1 Butterfly Network Profile
7.1.2 Butterfly Network Main Business
7.1.3 Butterfly Network Artificial Intelligence Diagnostics Products, Services, and Solutions
7.1.4 Butterfly Network Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.1.5 Butterfly Network Recent Developments
7.2 Merative
7.2.1 Merative Profile
7.2.2 Merative Main Business
7.2.3 Merative Artificial Intelligence Diagnostics Products, Services, and Solutions
7.2.4 Merative Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.2.5 Merative Recent Developments
7.3 Tempus
7.3.1 Tempus Profile
7.3.2 Tempus Main Business
7.3.3 Tempus Artificial Intelligence Diagnostics Products, Services, and Solutions
7.3.4 Tempus Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.3.5 Tempus Recent Developments
7.4 RetinAi
7.4.1 RetinAi Profile
7.4.2 RetinAi Main Business
7.4.3 RetinAi Artificial Intelligence Diagnostics Products, Services, and Solutions
7.4.4 RetinAi Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.4.5 RetinAi Recent Developments
7.5 Nanox
7.5.1 Nanox Profile
7.5.2 Nanox Main Business
7.5.3 Nanox Artificial Intelligence Diagnostics Products, Services, and Solutions
7.5.4 Nanox Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.5.5 Nanox Recent Developments
7.6 Lunit
7.6.1 Lunit Profile
7.6.2 Lunit Main Business
7.6.3 Lunit Artificial Intelligence Diagnostics Products, Services, and Solutions
7.6.4 Lunit Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.6.5 Lunit Recent Developments
7.7 DiA Imaging
7.7.1 DiA Imaging Profile
7.7.2 DiA Imaging Main Business
7.7.3 DiA Imaging Artificial Intelligence Diagnostics Products, Services, and Solutions
7.7.4 DiA Imaging Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.7.5 DiA Imaging Recent Developments
7.8 Subtle Medical
7.8.1 Subtle Medical Profile
7.8.2 Subtle Medical Main Business
7.8.3 Subtle Medical Artificial Intelligence Diagnostics Products, Services, and Solutions
7.8.4 Subtle Medical Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.8.5 Subtle Medical Recent Developments
7.9 BrainMiner
7.9.1 BrainMiner Profile
7.9.2 BrainMiner Main Business
7.9.3 BrainMiner Artificial Intelligence Diagnostics Products, Services, and Solutions
7.9.4 BrainMiner Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.9.5 BrainMiner Recent Developments
7.10 GE
7.10.1 GE Profile
7.10.2 GE Main Business
7.10.3 GE Artificial Intelligence Diagnostics Products, Services, and Solutions
7.10.4 GE Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.10.5 GE Recent Developments
7.11 Siemens
7.11.1 Siemens Profile
7.11.2 Siemens Main Business
7.11.3 Siemens Artificial Intelligence Diagnostics Products, Services, and Solutions
7.11.4 Siemens Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.11.5 Siemens Recent Developments
7.12 Aidoc
7.12.1 Aidoc Profile
7.12.2 Aidoc Main Business
7.12.3 Aidoc Artificial Intelligence Diagnostics Products, Services, and Solutions
7.12.4 Aidoc Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.12.5 Aidoc Recent Developments
7.13 Imagen Technologies, Inc.
7.13.1 Imagen Technologies, Inc. Profile
7.13.2 Imagen Technologies, Inc. Main Business
7.13.3 Imagen Technologies, Inc. Artificial Intelligence Diagnostics Products, Services, and Solutions
7.13.4 Imagen Technologies, Inc. Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.13.5 Imagen Technologies, Inc. Recent Developments
7.14 VUNO, Inc.
7.14.1 VUNO, Inc. Profile
7.14.2 VUNO, Inc. Main Business
7.14.3 VUNO, Inc. Artificial Intelligence Diagnostics Products, Services, and Solutions
7.14.4 VUNO, Inc. Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.14.5 VUNO, Inc. Recent Developments
7.15 Digital Diagnostics
7.15.1 Digital Diagnostics Profile
7.15.2 Digital Diagnostics Main Business
7.15.3 Digital Diagnostics Artificial Intelligence Diagnostics Products, Services, and Solutions
7.15.4 Digital Diagnostics Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.15.5 Digital Diagnostics Recent Developments
7.16 NeuraSignal
7.16.1 NeuraSignal Profile
7.16.2 NeuraSignal Main Business
7.16.3 NeuraSignal Artificial Intelligence Diagnostics Products, Services, and Solutions
7.16.4 NeuraSignal Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.16.5 NeuraSignal Recent Developments
7.17 Riverain Technologies, LLC
7.17.1 Riverain Technologies, LLC Profile
7.17.2 Riverain Technologies, LLC Main Business
7.17.3 Riverain Technologies, LLC Artificial Intelligence Diagnostics Products, Services, and Solutions
7.17.4 Riverain Technologies, LLC Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.17.5 Riverain Technologies, LLC Recent Developments
7.18 Philips
7.18.1 Philips Profile
7.18.2 Philips Main Business
7.18.3 Philips Artificial Intelligence Diagnostics Products, Services, and Solutions
7.18.4 Philips Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.18.5 Philips Recent Developments
7.19 Microsoft
7.19.1 Microsoft Profile
7.19.2 Microsoft Main Business
7.19.3 Microsoft Artificial Intelligence Diagnostics Products, Services, and Solutions
7.19.4 Microsoft Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.19.5 Microsoft Recent Developments
7.20 Viz.ai
7.20.1 Viz.ai Profile
7.20.2 Viz.ai Main Business
7.20.3 Viz.ai Artificial Intelligence Diagnostics Products, Services, and Solutions
7.20.4 Viz.ai Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.20.5 Viz.ai Recent Developments
7.21 RapidAI
7.21.1 RapidAI Profile
7.21.2 RapidAI Main Business
7.21.3 RapidAI Artificial Intelligence Diagnostics Products, Services, and Solutions
7.21.4 RapidAI Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.21.5 RapidAI Recent Developments
7.22 Canon Medical
7.22.1 Canon Medical Profile
7.22.2 Canon Medical Main Business
7.22.3 Canon Medical Artificial Intelligence Diagnostics Products, Services, and Solutions
7.22.4 Canon Medical Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.22.5 Canon Medical Recent Developments
7.23 Enlitic
7.23.1 Enlitic Profile
7.23.2 Enlitic Main Business
7.23.3 Enlitic Artificial Intelligence Diagnostics Products, Services, and Solutions
7.23.4 Enlitic Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.23.5 Enlitic Recent Developments
7.24 BioMind
7.24.1 BioMind Profile
7.24.2 BioMind Main Business
7.24.3 BioMind Artificial Intelligence Diagnostics Products, Services, and Solutions
7.24.4 BioMind Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.24.5 BioMind Recent Developments
7.25 ANNALISE-AI PTY LTD
7.25.1 ANNALISE-AI PTY LTD Profile
7.25.2 ANNALISE-AI PTY LTD Main Business
7.25.3 ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Products, Services, and Solutions
7.25.4 ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.25.5 ANNALISE-AI PTY LTD Recent Developments
7.26 icometrix
7.26.1 icometrix Profile
7.26.2 icometrix Main Business
7.26.3 icometrix Artificial Intelligence Diagnostics Products, Services, and Solutions
7.26.4 icometrix Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.26.5 icometrix Recent Developments
7.27 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
7.27.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Profile
7.27.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Main Business
7.27.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Artificial Intelligence Diagnostics Products, Services, and Solutions
7.27.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Artificial Intelligence Diagnostics Revenue (US$ Million), 2021–2026
7.27.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Developments
8 Industry Chain Analysis
8.1 Artificial Intelligence Diagnostics Value Chain
8.2 Artificial Intelligence Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Artificial Intelligence Diagnostics Sales Model
8.5.2 Sales Channels
8.5.3 Artificial Intelligence Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Artificial Intelligence Diagnostics market is projected to grow from US$ 7259 million in 2025 to US$ 27456 million by 2032, at a CAGR of 20.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-09
Pages: 187
USD 4900.00
(Single User License)
The global Artificial Intelligence Diagnostics market size was US$ 7259 million in 2025 and is forecast to reach a readjusted size of US$ 27456 million by 2032 with a CAGR of 20.9% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 128
USD 4250.00
(Single User License)
The global Artificial Intelligence Diagnostics market was valued at US$ 7259 million in 2025 and is anticipated to reach US$ 27456 million by 2032, at a CAGR of 20.9% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 171
USD 2900.00
(Single User License)
The global Artificial Intelligence Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 144
USD 4900.00
(Single User License)
The global Artificial Intelligence Diagnostics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 94
USD 4250.00
(Single User License)
The global market for Artificial Intelligence Diagnostics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 116
USD 3950.00
(Single User License)
The global market for Artificial Intelligence Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 88
USD 2900.00
(Single User License)
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published Date: 2024-04-07
Pages: 106
USD 4900.00
(Single User License)
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published Date: 2024-02-19
Pages: 102
USD 3950.00
(Single User License)
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published Date: 2024-02-07
Pages: 85
USD 2900.00
(Single User License)
The global Artificial Intelligence Diagnostics market is projected to grow from US$ 7259 million in 2025 to US$ 27456 million by 2032, at a CAGR of 20.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-09
Pages: 187
The global Artificial Intelligence Diagnostics market size was US$ 7259 million in 2025 and is forecast to reach a readjusted size of US$ 27456 million by 2032 with a CAGR of 20.9% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 128
The global Artificial Intelligence Diagnostics market was valued at US$ 7259 million in 2025 and is anticipated to reach US$ 27456 million by 2032, at a CAGR of 20.9% from 2026 to 2032.
Published: 2026-03-05
Pages: 171
The global Artificial Intelligence Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 144
The global Artificial Intelligence Diagnostics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 94
The global market for Artificial Intelligence Diagnostics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 116
The global market for Artificial Intelligence Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 88
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published: 2024-04-07
Pages: 106
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published: 2024-02-19
Pages: 102
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published: 2024-02-07
Pages: 85
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now